| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 03/05/2015 | WO2015031789A1 Electromechanical polymer pumps |
| 03/05/2015 | WO2015031756A1 Novel 2,4-dinitrophenol formulations and methods using same |
| 03/05/2015 | WO2015031681A1 Micronized placental compositions comprising a chelator |
| 03/05/2015 | WO2015031663A1 Edible coating compositions, edible coatings, and methods for making and using the same |
| 03/05/2015 | WO2015031654A2 Systems, compositions, and methods for transplantation and treating conditions |
| 03/05/2015 | WO2015031552A1 Estradiol containing transdermal drug delivery systems and compositions |
| 03/05/2015 | WO2015031536A1 Nanoparticle drug delivery system and method of treating cancer and neurotrauma |
| 03/05/2015 | WO2015031410A1 Single-layer oral dose of neuro-attenuating ketamine |
| 03/05/2015 | WO2015031405A1 Formulations of aminoglycosides and fosfomycin in a combination having improved chemical properties |
| 03/05/2015 | WO2015030854A1 Solid dispersion formulation of an antiviral compound |
| 03/05/2015 | WO2015030853A1 Combination formulation of two antiviral compounds |
| 03/05/2015 | WO2015029948A1 Prophylactic or therapeutic agent for retinal disease caused by retinal pigment epithelium disorder |
| 03/05/2015 | WO2015029926A1 Ophthalmological composition |
| 03/05/2015 | WO2015029924A1 Ophthalmological composition |
| 03/05/2015 | WO2015029923A1 Ophthalmological preparation |
| 03/05/2015 | WO2015029717A1 Ophthalmic solution |
| 03/05/2015 | WO2015028972A1 Pulsatile-release dosage form |
| 03/05/2015 | WO2015028920A1 Ionic gelation on solids |
| 03/05/2015 | WO2015028919A1 Agent for the treatment and prevention of cancer |
| 03/05/2015 | WO2015028901A1 A nanostructure for the vehiculation of gas and/or active ingredients and/or contrast agents and uses thereof |
| 03/05/2015 | WO2015028637A1 Novel drug formulation |
| 03/05/2015 | WO2015028541A1 Antigen delivery device and method |
| 03/05/2015 | WO2015028473A1 Pharmaceutical composition containing dimethyl fumarate for administration at a low daily dose |
| 03/05/2015 | WO2015028472A1 Pharmaceutical composition containing dimethyl fumarate for administration at a low daily dose |
| 03/05/2015 | WO2015028286A1 Polymeric synthetic antidote |
| 03/05/2015 | WO2015027949A1 Application of deuterated fumaric acid derivatives in treatment of multiple sclerosis |
| 03/05/2015 | WO2015027848A1 Method of administering formulation comprising peramivir and/or derivative thereof |
| 03/05/2015 | WO2015027565A1 L-carnitine micro-capsule powder and preparation method thereof |
| 03/05/2015 | WO2015027342A1 Microgel compositions for delivery of substances to the brain |
| 03/05/2015 | WO2015027303A1 Method for manufacturing a pharmaceutical combination containing an analgesic agent and an antispasmodic agent and pharmaceutical combination |
| 03/05/2015 | WO2014210504A9 Tape having transdermal analgesic properties |
| 03/05/2015 | WO2014210285A9 Oral drug delivery device and methods of using same |
| 03/05/2015 | US20150065790 Method for treating fecal incontinence |
| 03/05/2015 | US20150065582 Orally Dissolving Formulations of Memantine |
| 03/05/2015 | US20150065553 Stabilized statin formulations |
| 03/05/2015 | US20150065548 Composition comprising an organic diluent and a cellulose ether |
| 03/05/2015 | US20150065547 Esterified cellulose ethers having a specific substituent distribution |
| 03/05/2015 | US20150065491 Administration of benzodiazepine compositions |
| 03/05/2015 | US20150065484 Sustained release dosage forms for a jak1 inhibitor |
| 03/05/2015 | US20150065474 Dexamethasone formulations in a biodegradable material |
| 03/05/2015 | US20150065473 Method for visual enhancement and post procedure treatment protocol |
| 03/05/2015 | US20150065472 Intrauterine application of 18-methyl-15ss,16ss-methylene-19-nor-20-spirox-4-en-3-one systems, intrauterine systems containing 18-methyl-15ss,16ss-methylene-19-nor-20-spirox-4-en-3-one, as well as the use thereof in contraception and gynaecological therapy |
| 03/05/2015 | US20150065461 Vesicular Formulations for Use in the Treatment of Pain or Reduced Mobility of a Joint |
| 03/05/2015 | US20150065458 Composition for Inactivating an Enveloped Virus |
| 03/05/2015 | US20150065443 Embelin-based delivery system for water-insoluble active agents |
| 03/05/2015 | US20150065431 Reducing cutaneous scar formation and treating skin conditions |
| 03/05/2015 | US20150065423 Rapid acting injectable formulations |
| 03/05/2015 | US20150065422 Substituted diketopiperazine analogs for use as drug delivery agents |
| 03/05/2015 | US20150064288 Anti-Microbial Composition |
| 03/05/2015 | US20150064282 Use of neu1 sialidase inhibitors in the treatment of cancer |
| 03/05/2015 | US20150064278 Continuous Methods for Treating Liquids and Manufacturing Certain Constituents (e.g., Nanoparticles) in Liquids, Apparatuses and Nanoparticles and Nanoparticle/Liquid Solution(s) Resulting Therefrom |
| 03/05/2015 | US20150064270 Composition and method for effective lean body mass gain |
| 03/05/2015 | US20150064269 Method for producing dry earthworm powder |
| 03/05/2015 | US20150064268 Nanoparticles for stimulating elastogenesis |
| 03/05/2015 | US20150064267 Nanoparticles for controlled lysis of blood clots |
| 03/05/2015 | US20150064266 Methods and compositions for treating conditions related to lack of blood supply, shock and neuronal injuries |
| 03/05/2015 | US20150064265 Vehicles for Controlled Delivery of Different Pharmaceutical Agents |
| 03/05/2015 | US20150064264 Pharmaceutical dosage forms comprising a low-solubility drug and a polymer |
| 03/05/2015 | US20150064263 Compositions and methods for reduction of mercury toxicity |
| 03/05/2015 | US20150064262 Nitazoxadine composition and process to prepare same |
| 03/05/2015 | US20150064261 Multiparticulate L-Menthol Formulations and Related Methods |
| 03/05/2015 | US20150064259 Methods and compositions for treating conditions related to lack of blood supply, shock and neuronal injuries |
| 03/05/2015 | US20150064258 Diclofenac formulations and methods of use |
| 03/05/2015 | US20150064256 Porous carbon particles for use in the treatment or prevention of liver disease |
| 03/05/2015 | US20150064255 Nanostructures for treating cancers and other conditions |
| 03/05/2015 | US20150064254 Method for treatment of pain and inflammation |
| 03/05/2015 | US20150064253 Combination formulation of two antiviral compounds |
| 03/05/2015 | US20150064251 Tamper Resistant Dosage Form Composition And Process Of Making The Same |
| 03/05/2015 | US20150064250 Tamper-Resistant Pharmaceutical Dosage Forms |
| 03/05/2015 | US20150064249 Pharmaceutical tablet formulation for the veterinary medical sector, method of production and use thereof |
| 03/05/2015 | US20150064248 Abuse resistant forms of extended release hydromorphone, method of use and method of making |
| 03/05/2015 | US20150064247 Abuse resistant forms of immediate release hydrocodone, method of use and method of making |
| 03/05/2015 | US20150064246 Abuse resistant forms of extended release oxymorphone, method of use and method of making |
| 03/05/2015 | US20150064245 Abuse Resistant Forms of Immediate Release Hydromorphone, Method of Use and Method of Making |
| 03/05/2015 | US20150064244 Konjac formulation and method for preparing the same |
| 03/05/2015 | US20150064243 Pharmaceutical compositions and dosage forms for admininistration of hydrophobic drugs |
| 03/05/2015 | US20150064242 Trialkyl cationic lipids and methods of use thereof |
| 03/05/2015 | US20150064241 Delivery of Functionalized Particles |
| 03/05/2015 | US20150064240 MUC1 Based Glycolipopeptide Vaccine with Adjuvant |
| 03/05/2015 | US20150064237 Medicinal composition for treating infarction |
| 03/05/2015 | US20150064236 Modified polynucleotides for the production of proteins |
| 03/05/2015 | US20150064234 4-aminopyridine as a therapeutic agent for spinal muscular atrophy |
| 03/05/2015 | US20150064233 Lipid-coated nucleic acid nanostructures of defined shape |
| 03/05/2015 | US20150064232 Transdermal absorption preparation |
| 03/05/2015 | US20150064231 Oral film containing opiate enteric-release beads |
| 03/05/2015 | US20150064230 Sustained release delivery of one or more agents |
| 03/05/2015 | US20150064223 Biguanide Compositions and Methods of Treating Metabolic Disorders |
| 03/05/2015 | US20150064166 Lyophilized Preparation of Botulinum Toxin |
| 03/05/2015 | US20150064118 Lipid depot formulations |
| 03/05/2015 | US20150064115 Neurophilic nanoparticles |
| 03/05/2015 | US20150064114 Liposome including hydrophobic material and imaging agent and use of the liposome |
| 03/05/2015 | US20150060581 Production of Near Monodisperse Particles using Milling and Membrane Separation |
| 03/05/2015 | US20150059746 Method and apparatus |
| 03/05/2015 | DE102013014417A1 Schwammkollagen umfassende Zubereitungen mit definiertem in vivo-Freisetzungsprofil vor allem im Colon, deren Herstellung und Verwendung Collagen sponge comprehensive preparations defined in vivo release profile especially in the colon, their preparation and use |
| 03/04/2015 | EP2842942A1 Trans-2-decenoic acid derivative and drug containing same |
| 03/04/2015 | EP2842574A1 Sustained release carrier for drugs |
| 03/04/2015 | EP2842553A1 Analgesic |
| 03/04/2015 | EP2842550A1 Compositions comprising sponge collagen with a defined in vivo release profile, especially in the colon, their preparation and use |
| 03/04/2015 | EP2842549A1 Orally disintegrating tablet and method for producing same |
| 03/04/2015 | EP2842548A1 Polymeric synthetic antidote |